Sign In
Buy AWH
$0.0820
+0 (+0%)
At Close: Jul 30, 2025
Aspira Women's Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women's Health
09:02am, Tuesday, 26'th May 2026
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation AUSTIN, TX AND CLEVELAND, OH / ACCESS Newswire / May 26,
AWH Reports First Quarter 2026 Financial Results
04:00pm, Wednesday, 13'th May 2026
Generated Q1 2026 net revenue of $116.9 million and Adjusted EBITDA1 of $26.3 million 51-location footprint to date, with five dispensaries added in 20262 Ranked No. 2 brand house in Illinois, Massach
AWH to Hold First Quarter 2026 Earnings Conference Call on Wednesday, May 13, 2026
08:00am, Wednesday, 29'th Apr 2026
NEW YORK, April 29, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator
AUSTIN, TX / ACCESS Newswire / April 23, 2026 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI-enhanced bio-analytics company focused on the development of noninvasive gynecologic disease d
AWH Announces Fourth Quarter and Full Year 2025 Results
04:00pm, Thursday, 12'th Mar 2026
Delivered Q4 2025 and FY 2025 revenue of $120.5 million and $500.6 million Expanded Adjusted EBITDA Margin 1 to 25.1% in Q4 2025 and 23.4% for FY 2025 Maintained strong liquidity with $ 85.7 million
AWH Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results and Conference Call Date
08:00am, Monday, 09'th Feb 2026
Q4 2025 and FY 2025 revenue expected to be ~$120 million and ~$500 million, respectively Q4 2025 and FY 2025 Adjusted EBITDA projected at ~$30 million and ~$117 million Balance sheet strength wi
Aspira Announces Third Quarter 2025 Financial Results and Provides Business Update
07:35am, Friday, 14'th Nov 2025
AUSTIN, TX / ACCESS Newswire / November 14, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQX:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasi
AWH Announces Third Quarter 2025 Financial Results
04:00pm, Monday, 10'th Nov 2025
Delivered Q3 2025 Net Revenue of $124.7 million Achieved Q3 2025 Adjusted EBITDA1 of $31.1 million, representing a 24.9% margin Focused margin optimization fueled sequential Adjusted Gross Margin 1 �
Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston
07:00am, Wednesday, 29'th Oct 2025
Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., abi
AWH to Hold Third Quarter 2025 Earnings Conference Call on Monday, November 10, 2025
08:00am, Monday, 20'th Oct 2025
NEW YORK , Oct. 20, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, today an
AWH Closes $9.3 Million Mortgage Financing on Three Ohio Properties
08:00am, Tuesday, 30'th Sep 2025
NEW YORK , Sept. 30, 2025 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH" or the "Company") (CSE: AAWH.U) (OTCQX: AAWH), a leading multi-state, vertically integrated cannabis operator, entered
Aspira Women's Health Announces Equity Capital Infusion of $3.06 Million in Private Placement and Warrant Exercise
07:00am, Thursday, 18'th Sep 2025
$2.95 Million PIPE $112 thousand warrant exercise AUSTIN, TX / ACCESS Newswire / September 18, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's hea
Aspira Women's Health Appoints New Chief Financial Officer
07:00am, Thursday, 04'th Sep 2025
New Executive Brings 20+ Years of Accounting, Capital Markets & Biotechnology Experience AUSTIN, TX / ACCESS Newswire / September 4, 2025 / Aspira Women's Health Inc. ("Aspira" or the "Company") (QTCQ
Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update
06:00am, Wednesday, 13'th Aug 2025
AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive
AWH Announces Second Quarter 2025 Financial Results
04:00pm, Thursday, 07'th Aug 2025
Q2 2025 Net Revenue of $127.3 million and Adjusted EBITDA 1 of $28.6 million Tenth straight quarter of positive operating cash flow with $17.8 million generated Fully retired $60 million term loan v
